Table 4.
Association between use of oral antibiotics and risk of early-onset colorectal cancer (age < 50 years) by anatomic location
Nonusers | Users | OR (95% CI) | ||||
Cases (n) | Controls (n) | Cases (n) | Controls (n) | Model 1a | Model 2b | |
Proximal colon | ||||||
All antibiotics | 92 | 481 | 126 | 587 | 1.14 (0.83, 1.57) | 0.99 (0.71, 1.39) |
Spectrum of coverage | ||||||
Broad spectrum | 152 | 778 | 66 | 290 | 1.18 (0.84, 1.64) | 0.94 (0.65, 1.35) |
Narrow spectrum | 113 | 578 | 105 | 490 | 1.11 (0.82, 1.52) | 1.04 (0.75, 1.45) |
Bacterial target | ||||||
Antiaerobic | 94 | 496 | 124 | 572 | 1.17 (0.85, 1.61) | 1.01 (0.72, 1.42) |
Antianaerobic | 194 | 968 | 24 | 100 | 1.21 (0.74, 1.96) | 0.79 (0.45, 1.41) |
Distal colon | ||||||
All antibiotics | 131 | 685 | 178 | 852 | 1.11 (0.85, 1.45) | 1.05 (0.79, 1.39) |
Spectrum of coverage | ||||||
Broad spectrum | 210 | 1,088 | 99 | 449 | 1.15 (0.88, 1.53) | 1.12 (0.84, 1.50) |
Narrow spectrum | 157 | 831 | 152 | 706 | 1.15 (0.88, 1.50) | 1.08 (0.81, 1.43) |
Bacterial target | ||||||
Antiaerobic | 134 | 698 | 175 | 839 | 1.11 (0.85, 1.44) | 1.04 (0.79, 1.38) |
Antianaerobic | 264 | 1,353 | 45 | 184 | 1.26 (0.87, 1.80) | 1.13 (0.77, 1.66) |
Rectal | ||||||
All antibiotics | 424 | 2,198 | 506 | 2,380 | 1.12 (0.96, 1.31) | 1.04 (0.88, 1.22) |
Spectrum of coverage | ||||||
Broad spectrum | 659 | 3,386 | 271 | 1,192 | 1.18 (1.00, 1.38) | 1.06 (0.90, 1.26) |
Narrow spectrum | 524 | 2,589 | 406 | 1989 | 1.01 (0.87, 1.18) | 0.93 (0.79, 1.09) |
Bacterial target | ||||||
Antiaerobic | 437 | 2,247 | 493 | 2,331 | 1.10 (0.94, 1.28) | 1.01 (0.86, 1.19) |
Antianaerobic | 824 | 4,133 | 106 | 445 | 1.20 (0.95, 1.50) | 0.98 (0.77, 1.26) |
CI, confidence interval.
Conditional logistic regression was used with matching for age (continuous), sex (binary), calendar year at the time of match, and county of residence.
Multivariable conditional logistic regression models were further adjusted for education (9 years or less, 10–12 years, ≥13 years, and missing), number of clinic visits (continuous), number of hospitalizations (continuous), Charlson Comorbidity Score (continuous), and number of previous lower endoscopies (continuous).